Brian Whitlock, Vice President of Global R&D Procurement at Bristol Myers Squibb shares his experience in designing a high-performance operating model to support the business objectives of biopharmaceutical research.
Mark Burfoot, VP Research Procurement at Novartis explains how advances in Machine Learning allow procurement to have a more strategic role in optimising life science research.
Virginie Mathieu she shares her experiences in supporting the experimental end of pharma and advice for partnering with scientists.
Dr. Thortsen Fallisch, Head of Global R&D Procurement at Grünenthal spoke to PharmaSource about his experience in setting up a Procurement Centre of Excellence and why speed can be more important than savings.
